Bispecific antibodies for viral immunotherapy. 2017

Elisabeth K Nyakatura, and Alexandra Y Soare, and Jonathan R Lai
a Department of Biochemistry , Albert Einstein College of Medicine , Bronx , NY , USA.

Bispecific antibody engineering, in which binding specificities toward 2 distinct epitopes are combined into a single molecule, can greatly enhance immunotherapeutic properties of monoclonal antibodies. While the bispecific antibody approach has been applied widely to targets for indications such as cancer and inflammation, the development of such agents for viral immunotherapy is only now emerging. Here, we review recent advances in the development of bispecific antibodies for viral immunotherapy, highlighting promising in vitro and in vivo results.

UI MeSH Term Description Entries
D007155 Immunologic Factors Biologically active substances whose activities affect or play a role in the functioning of the immune system. Biological Response Modifier,Biomodulator,Immune Factor,Immunological Factor,Immunomodulator,Immunomodulators,Biological Response Modifiers,Biomodulators,Factors, Immunologic,Immune Factors,Immunological Factors,Modifiers, Biological Response,Response Modifiers, Biological,Factor, Immune,Factor, Immunological,Factors, Immune,Factors, Immunological,Modifier, Biological Response,Response Modifier, Biological
D007167 Immunotherapy Manipulation of the host's immune system in treatment of disease. It includes both active and passive immunization as well as immunosuppressive therapy to prevent graft rejection. Immunotherapies
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal
D000914 Antibodies, Viral Immunoglobulins produced in response to VIRAL ANTIGENS. Viral Antibodies
D014777 Virus Diseases A general term for diseases caused by viruses. Viral Diseases,Viral Infections,Virus Infections,Disease, Viral,Disease, Virus,Diseases, Viral,Diseases, Virus,Infection, Viral,Infection, Virus,Infections, Viral,Infections, Virus,Viral Disease,Viral Infection,Virus Disease,Virus Infection
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus
D055808 Drug Discovery The process of finding chemicals for potential therapeutic use. Drug Prospecting,Discovery, Drug,Prospecting, Drug
D018033 Antibodies, Bispecific Antibodies, often monoclonal, in which the two antigen-binding sites are specific for separate ANTIGENIC DETERMINANTS. They are artificial antibodies produced by chemical crosslinking, fusion of HYBRIDOMA cells, or by molecular genetic techniques. They function as the main mediators of targeted cellular cytotoxicity and have been shown to be efficient in the targeting of drugs, toxins, radiolabeled haptens, and effector cells to diseased tissue, primarily tumors. Bifunctional Antibodies,Bispecific Antibodies,Bispecific Monoclonal Antibodies,Antibodies, Bifunctional,Antibodies, Bispecific Monoclonal,Monoclonal Antibodies, Bispecific

Related Publications

Elisabeth K Nyakatura, and Alexandra Y Soare, and Jonathan R Lai
October 2021, Clinical cancer research : an official journal of the American Association for Cancer Research,
Elisabeth K Nyakatura, and Alexandra Y Soare, and Jonathan R Lai
January 1995, Verhandelingen - Koninklijke Academie voor Geneeskunde van Belgie,
Elisabeth K Nyakatura, and Alexandra Y Soare, and Jonathan R Lai
August 2007, Current opinion in molecular therapeutics,
Elisabeth K Nyakatura, and Alexandra Y Soare, and Jonathan R Lai
April 2010, BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy,
Elisabeth K Nyakatura, and Alexandra Y Soare, and Jonathan R Lai
May 2012, Immunotherapy,
Elisabeth K Nyakatura, and Alexandra Y Soare, and Jonathan R Lai
February 2018, Therapeutic advances in vaccines and immunotherapy,
Elisabeth K Nyakatura, and Alexandra Y Soare, and Jonathan R Lai
October 2016, Human vaccines & immunotherapeutics,
Elisabeth K Nyakatura, and Alexandra Y Soare, and Jonathan R Lai
October 2020, Current opinion in biotechnology,
Elisabeth K Nyakatura, and Alexandra Y Soare, and Jonathan R Lai
July 2011, Expert opinion on biological therapy,
Elisabeth K Nyakatura, and Alexandra Y Soare, and Jonathan R Lai
January 2020, Frontiers in oncology,
Copied contents to your clipboard!